DZ3050A1 - Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques. - Google Patents

Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques.

Info

Publication number
DZ3050A1
DZ3050A1 DZ000101A DZ000101A DZ3050A1 DZ 3050 A1 DZ3050 A1 DZ 3050A1 DZ 000101 A DZ000101 A DZ 000101A DZ 000101 A DZ000101 A DZ 000101A DZ 3050 A1 DZ3050 A1 DZ 3050A1
Authority
DZ
Algeria
Prior art keywords
octane
crystalline
pharmaceutical compositions
polymorphic forms
amine citrate
Prior art date
Application number
DZ000101A
Other languages
English (en)
French (fr)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ3050A1 publication Critical patent/DZ3050A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ000101A 1999-06-01 2000-05-31 Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques. DZ3050A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
DZ3050A1 true DZ3050A1 (fr) 2004-03-27

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000101A DZ3050A1 (fr) 1999-06-01 2000-05-31 Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques.

Country Status (49)

Country Link
US (1) US6255320B1 (es)
EP (1) EP1181290B1 (es)
JP (1) JP3830816B2 (es)
KR (1) KR100476606B1 (es)
CN (1) CN1146565C (es)
AP (1) AP2001002349A0 (es)
AR (1) AR033331A1 (es)
AT (1) ATE244239T1 (es)
AU (1) AU767334B2 (es)
BG (1) BG65240B1 (es)
BR (1) BR0011094A (es)
CA (1) CA2372238C (es)
CO (1) CO5170463A1 (es)
CY (1) CY2007011I2 (es)
CZ (1) CZ295819B6 (es)
DE (1) DE60003679T2 (es)
DK (1) DK1181290T3 (es)
DZ (1) DZ3050A1 (es)
EA (1) EA003731B1 (es)
EC (1) ECSP003508A (es)
EE (1) EE200100656A (es)
ES (1) ES2199825T3 (es)
GT (1) GT200000087A (es)
HK (1) HK1046284A1 (es)
HN (1) HN2000000077A (es)
HR (1) HRP20010904A2 (es)
HU (1) HUP0201301A3 (es)
IL (1) IL146406A0 (es)
MA (1) MA26742A1 (es)
MX (1) MXPA01012325A (es)
MY (1) MY133508A (es)
NO (1) NO20015848L (es)
NZ (1) NZ515349A (es)
OA (1) OA11956A (es)
PA (1) PA8496101A1 (es)
PE (1) PE20010209A1 (es)
PL (1) PL196046B1 (es)
PT (1) PT1181290E (es)
SI (1) SI1181290T1 (es)
SK (1) SK285820B6 (es)
SV (1) SV2001000093A (es)
TN (1) TNSN00120A1 (es)
TR (1) TR200103473T2 (es)
TW (1) TWI285204B (es)
UA (1) UA66925C2 (es)
UY (1) UY26176A1 (es)
WO (1) WO2000073304A1 (es)
YU (1) YU81101A (es)
ZA (1) ZA200109775B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2337685C2 (ru) 2004-01-30 2008-11-10 Пфайзер Продактс Инк. Антагонисты нейрокининового рецептора nk-1 для выхода из наркоза
AU2005216707A1 (en) * 2004-01-30 2005-09-09 Pfizer Products Inc. Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
US8183230B2 (en) * 2004-01-30 2012-05-22 Pfizer Inc. Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
ES2296131T3 (es) * 2004-02-02 2008-04-16 Pfizer Products Incorporated Procedimiento para la preparacion de 1-(2s,3s)-2-bencidril-n-(5-terc-butil-2-metoxibencil)quinuclidin-3-amina.
MX361286B (es) * 2013-03-15 2018-12-03 Pearl Therapeutics Inc Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639A (zh) * 2019-12-16 2021-06-18 四川科瑞德凯华制药有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK390692A3 (en) * 1991-05-31 1998-02-04 Pfizer Quinuclidine derivatives, preparation method thereof and use
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
PL196046B1 (pl) 2007-11-30
PT1181290E (pt) 2003-09-30
EE200100656A (et) 2003-02-17
UA66925C2 (uk) 2004-06-15
DK1181290T3 (da) 2003-09-29
CY2007011I1 (el) 2010-07-28
EP1181290B1 (en) 2003-07-02
SK17332001A3 (sk) 2002-07-02
SK285820B6 (sk) 2007-09-06
EA003731B1 (ru) 2003-08-28
ZA200109775B (en) 2002-11-28
GT200000087A (es) 2001-11-22
NO20015848D0 (no) 2001-11-30
PL352716A1 (en) 2003-09-08
HUP0201301A2 (en) 2002-08-28
PA8496101A1 (es) 2002-07-30
MY133508A (en) 2007-11-30
CA2372238A1 (en) 2000-12-07
CZ295819B6 (cs) 2005-11-16
OA11956A (en) 2006-04-13
CA2372238C (en) 2006-12-19
AR033331A1 (es) 2003-12-17
ES2199825T3 (es) 2004-03-01
SI1181290T1 (en) 2003-12-31
PE20010209A1 (es) 2001-03-01
TNSN00120A1 (fr) 2005-11-10
HK1046284A1 (en) 2003-01-03
DE60003679T2 (de) 2004-05-27
ATE244239T1 (de) 2003-07-15
CY2007011I2 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
ECSP003508A (es) 2002-02-25
SV2001000093A (es) 2001-11-08
BG106204A (en) 2002-07-31
DE60003679D1 (de) 2003-08-07
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
CZ20014269A3 (cs) 2002-04-17
MXPA01012325A (es) 2002-07-22
BG65240B1 (bg) 2007-09-28
EP1181290A1 (en) 2002-02-27
BR0011094A (pt) 2002-03-19
KR20020010688A (ko) 2002-02-04
AP2001002349A0 (en) 2001-12-31
HUP0201301A3 (en) 2002-10-28
UY26176A1 (es) 2000-12-29
HN2000000077A (es) 2001-02-02
YU81101A (sh) 2004-07-15
KR100476606B1 (ko) 2005-03-18
NZ515349A (en) 2004-03-26
IL146406A0 (en) 2002-07-25
CO5170463A1 (es) 2002-06-27
CN1353711A (zh) 2002-06-12
CN1146565C (zh) 2004-04-21
TR200103473T2 (tr) 2002-04-22
EA200101108A1 (ru) 2002-04-25
WO2000073304A1 (en) 2000-12-07
MA26742A1 (fr) 2004-12-20
AU4424800A (en) 2000-12-18
JP3830816B2 (ja) 2006-10-11
JP2003501354A (ja) 2003-01-14
AU767334B2 (en) 2003-11-06
TWI285204B (en) 2007-08-11

Similar Documents

Publication Publication Date Title
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
LU92745I2 (fr) Nétupitant/Palonosétron et leurs dérivés pharmaceutiquement acceptables (AKYNZEOr)
MA26673A1 (fr) Composes pharmaceutiques
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
MA26816A1 (fr) Derives d'amino-triazolopyridine
ID26743A (id) Turunan 1,2,4,5-tetrahidro-benzo [d] azepin
FR2761265B1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
FR2761266B1 (fr) Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
NO20020976L (no) Retarderte, orale, farmasöytiske administreringsformer
NO20002686L (no) Forbedring av Peyronies sykdom
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
CY2007011I2 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
FR2833842B1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
DZ3055A1 (fr) Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant.
PT102384A (pt) Composicoes farmaceuticas compreendendo metanossulfonato de paroxentina
MA26604A1 (fr) Compositions pharmaceutiques.
IS6159A (is) Fjölgervingar af kristölluðu asabísýkló (2,2,2) oktan-3-amín sítrati og lyfjasamsetningar
ITMI20001848A0 (it) Faramaci per l'incontinenza.
IT1310325B1 (it) Metodo per la realizzazione di calzature e calzatura cosi' realizzata.
FR2791888B1 (fr) Suspension pharmaceutique buvable